Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control in Minimize Cognitive Decline

Launched by TULANE UNIVERSITY · Mar 11, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to help people with high blood pressure (hypertension) to lower their blood pressure significantly, with the goal of preventing cognitive decline, which is the gradual loss of mental abilities. The study specifically focuses on racial minority and low-income patients in primary care settings. Researchers want to see if an intensive treatment plan that targets a blood pressure of less than 120 mmHg can help protect against issues related to thinking and memory, especially in groups that often face health disparities.

To be eligible for this study, participants should be at least 40 years old, with a focus on those over 60. They will need to have high blood pressure readings at previous doctor visits and cannot have a diagnosis of dementia or serious kidney disease. The study is open to both men and women who receive care at clinics that serve mostly underserved populations and have the necessary medical record systems in place. Participants will be involved in a treatment plan that aims to lower their blood pressure while being monitored by healthcare professionals. This research hopes to provide valuable insights that can be used to improve healthcare strategies for preventing cognitive decline in communities that need it most.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria for Primary Care Clinics
• • Predominantly managing underserved populations with health disparities (ethnic minorities, low-income groups, and residents of rural areas and inner cities).
• • Having electronic medical record systems.
• • Serving \>200 hypertension patients (ICD-10-CM I10-I15) during the previous year.
• • Not participating in other hypertension control programs
• • Not sharing providers or nurses/pharmacists with other participating clinics.
• • Inclusion Criteria for Study Participants
• • Men or women aged ≥40 years (2/3 of participants ≥60 years) who receive primary care from participating clinics.
• • Systolic BP ≥ 140 mmHg at two screening visits for those not taking antihypertensive medication or systolic BP ≥ 130 mmHg at two screening visits for those taking antihypertensive medications
• • Pregnant women, women planning to become pregnant in the near future, women of childbearing potential and not practicing birth control, and persons who cannot give informed consent will be excluded.
• • No diagnosis of dementia at baseline
• • Baseline MoCA score ≥ 10.
• • No diagnosis of end-stage renal disease, defined as dialysis or transplantation
• • Speak English as first language
• • No plans to change to a primary healthcare provider outside of their clinic in the near future
• • No individuals unlikely to complete the study, such as those who plan to move out of the study area in the near future and temporary migrant and homeless people
• • No immediate family members are staff at their clinic